SECTION I: Introduction to Sociocultural Aspects, Law, and Ethics
Chapter 1: Sociocultural Aspects
– Medicine advertising and media influences
– Over-the-counter (OTC) preparations
– Generic vs proprietary medicines
– Medicine use in older individuals
– Cultural and linguistic differences
– Indigenous perspectives on medicine therapy
Chapter 2: Health Professionals and the Law
– Legislative controls on medicines
– Australian and New Zealand medicine controls
– Common law: unclear, telephone, standing orders
– Emergency situations and nurse practitioners
– Midwifery and remote area care
Chapter 3: Ethical Issues in Health Care
– Six principles: veracity, autonomy, non-maleficence, etc.
– Ethical situations in pharmacology
– Professional responsibilities
SECTION II: Medicine Administration and Professional Responsibilities
Chapter 4: Formulations, Storage, Routes
– Formulations and stability
– Routes of administration
– First-pass effect
Chapter 5: Clinical Decision-Making
– Clinical assessment
– Medicine selection
– Patient factors
Chapter 6: Administration and Documentation
– Administration techniques
– Documentation standards
– Responsibilities
Chapter 7: Medication Errors
– Types and causes
– Prevention strategies
– Reporting and management
,SECTION III: General Aspects of Pharmacology
Chapter 8: Drug Nomenclature
– Generic, brand, chemical names
– Classification systems
Chapter 9: Pharmacokinetics
– ADME process
– Bioavailability and half-life
Chapter 10: Pharmacodynamics
– Drug-receptor interactions
– Dose-response, agonists
Chapter 11: Pharmacogenetics
– Genetic factors
– Pharmacogenomic testing
Chapter 12: Drug Interactions
– Pharmacokinetic & dynamic
– Drug-food interactions
Chapter 13: Pharmacokinetic Modifiers
– Age, disease, environment
Chapter 14: Pediatric & Geriatric Pharmacology
– Developmental and dosing issues
SECTION IV: Toxicology
Chapter 15: Poisoning & Envenomation
Chapter 16: Acute Overdose
Chapter 17: Substances of Abuse
Chapter 18: Medicine Safety
SECTION V: Autonomic Pharmacology
Chapter 19: Neuropharmacology Overview
Chapter 20: Adrenergic Pharmacology
Chapter 21: Cholinergic Pharmacology
SECTION VI: Neuropharmacology
Chapter 22: Antipsychotic Agents
Chapter 23: Anxiolytics & Hypnotics
Chapter 24: Antidepressants & Mood Stabilisers
Chapter 25: Neurodegenerative Disorders
Chapter 26: Antiseizure Agents & Muscle Relaxants
Chapter 27: CNS Stimulants
,SECTION VII: Pain and Anaesthesia
Chapter 28: Analgesics
Chapter 29: Migraine & Headaches
Chapter 30: General Anaesthesia
Chapter 31: Local Anaesthesia
SECTION VIII: Inflammation, Immunity and Cancer
Chapter 32: Anti-inflammatory Agents
Chapter 33: Antigout Medicines
Chapter 34: Antihistamines
Chapter 35: Immunomodulators
Chapter 36: Cancer Chemotherapy
SECTION IX: Cardiovascular and Respiratory Pharmacology
Chapter 37: Dyslipidaemia
Chapter 38: Antihypertensives
Chapter 39: Antianginals
Chapter 40: Anticoagulants and Thrombolytics
Chapter 41: Diuretics & Renal Drugs
Chapter 42: Heart Failure
Chapter 43: Antidysrhythmics
Chapter 44: Fluid & Electrolyte Imbalance
Chapter 45: Anti-anaemic Agents
Chapter 46: Respiratory Medicines (Asthma, COPD)
SECTION X: Modulation of Gastrointestinal Function
Chapter 47: Cold & Allergy Medicines
Chapter 48: Gastrointestinal Drugs
Chapter 49: Antiemetics
Chapter 50: Nutrition (Enteral/Parenteral)
SECTION XI: Endocrine and Metabolic Pharmacology
Chapter 51: Pituitary Conditions
Chapter 52: Thyroid Conditions
Chapter 53: Diabetes Management
Chapter 54: Adrenal Disorders
Chapter 55: Gonadal Hormones
Chapter 56: Bone Disorders
Chapter 57: Obesity Management
,SECTION XII: Antimicrobial Pharmacology
Chapter 58: Intro to Antimicrobials
Chapter 59: Antibacterial Agents
Chapter 60: TB and Leprosy Agents
Chapter 61: Antiseptics & Disinfectants
Chapter 62: Antiparasitic Agents
Chapter 63: Antivirals
Chapter 64: Antifungals
SECTION XIII: Special Topics in Pharmacology
Chapter 65: Skin Conditions
Chapter 66: Ophthalmic Medicines
Chapter 67: Herbal Medicines
,Chapter 1
1. A community clinic notices increased patient requests
for a new pain reliever after a celebrity endorsement on
social media.
Correct answer: Celebrity endorsements in medicine
advertising can create perceived efficacy through social
influence.
Rationale: Media portrayals and endorsements shape
patient expectations by leveraging trust in public figures,
highlighting the need for pharmacists to critically appraise
advertised claims within their sociocultural impact.
2. A rural health worker observes patients believing that
“natural” herbal teas promoted online are safer than
prescribed analgesics.
Correct answer: Media often frames “natural” remedies as
inherently safe, influencing self‐medication behaviors.
Rationale: Advertising exploits cultural perceptions of
naturalness to drive OTC use, underscoring the
sociocultural bias toward herbal preparations despite lack
of standardized dosing.
3. A regulatory body reviews a pharmaceutical company’s
direct‐to‐consumer TV ads for cardiovascular drugs. What
sociocultural concern is most relevant?
Correct answer: These ads may medicalize normal aging,
leading to overdiagnosis driven by cultural norms around
health and performance.
,Rationale: Media influences can pathologize common life
stages, reflecting societal values on productivity and
longevity and potentially driving inappropriate prescribing.
4. An elderly patient purchases an OTC cold remedy
without consulting a pharmacist, believing it to be
risk-free.
Correct answer: OTC status often creates a false sense of
safety, particularly in vulnerable populations.
Rationale: Sociocultural norms equate prescription-only
with danger and OTC with harmlessness, masking risks like
drug–drug interactions in older adults.
5. A parent self‐medicates a child with an OTC
antihistamine based on a pharmacy advertisement. Which
factor is at play?
Correct answer: Advertising can bypass professional
advice, encouraging self-selection of OTC products.
Rationale: Media messaging that normalizes parental
decision-making for minor ailments reflects sociocultural
shifts toward consumer autonomy in healthcare.
6. Community health workers note a rise in
acetaminophen overdoses after promotional discounts in
pharmacies.
Correct answer: Price promotions on OTC medicines can
increase consumption beyond therapeutic needs.
Rationale: Sociocultural emphasis on cost savings can
,inadvertently encourage excessive dosing, demonstrating
the impact of marketing strategies on public health.
7. A multilingual grocery store stocks OTC painkillers with
English-only labels.
Correct answer: Language barriers in labeling impede safe
OTC medicine use among non-English speakers.
Rationale: Lack of linguistic accommodation reflects
cultural insensitivity, heightening risk of misuse in diverse
populations.
8. A patient asks why the pharmacy’s generic statin is less
expensive than the brand name.
Correct answer: Generic medicines contain the same
active ingredient but have lower marketing and
development costs.
Rationale: Sociocultural emphasis on innovation can
inflate perceptions of brand superiority, yet generics offer
equivalent efficacy at reduced societal cost.
9 A pharmacist explains bioequivalence to a patient
reluctant to switch from a proprietary antidepressant to its
generic.
Correct answer: Regulatory agencies require generic drugs
to demonstrate pharmacokinetic equivalence to branded
formulations.
Rationale: Trust in pharmaceutical branding is culturally
ingrained, so educating on bioequivalence tackles
misconceptions rooted in marketing influence.
,10. A community with limited income shows higher
uptake of proprietary antidiabetics due to aggressive
discount programs.
Correct answer: Financial incentives for brand drugs can
override cost‐saving potential of generics.
Rationale: Sociocultural factors like perceived prestige and
targeted subsidy programs shape medication choices,
sometimes counteracting public health cost‐effectiveness.
11. A migrant patient insists on a brand‐name
antihypertensive from their home country, despite
availability of a local generic.
Correct answer: Cultural familiarity influences preference
for proprietary products.
Rationale: Sociocultural trust in medicines from one’s
country of origin can impact adherence and willingness to
accept local generic alternatives.
12. An 80-year-old patient with polypharmacy
experiences dizziness after starting a new medication.
What sociocultural factor is relevant?
Correct answer: Ageism in healthcare may lead to
underassessment of pharmacokinetic changes in older
adults.
Rationale: Societal undervaluing of older individuals can
result in inadequate counseling and monitoring, increasing
ADR risk.
, 13. A community centre offers workshops on safe
medicine use for seniors. Why is this significant?
Correct answer: Tailored education acknowledges the
unique pharmacotherapeutic needs of older adults.
Rationale: Sociocultural commitment to lifelong learning
can empower older patients to manage complex regimens
and minimize adverse events.
14. A pharmacy labels blister packs by day and time for an
elderly patient with dementia.
Correct answer: Simplified packaging addresses cognitive
and cultural needs of older individuals.
Rationale: Respecting the sociocultural context of
age-related cognitive decline, such interventions support
adherence and autonomy.
15. An older immigrant patient avoids taking prescribed
diabetes medication due to cultural beliefs about illness.
Correct answer: Cultural health beliefs can influence
medicine acceptance among older adults.
Rationale: Recognizing cultural explanatory models is
essential to tailor interventions and overcome barriers
rooted in traditional views of disease and therapy.
16. A hospital uses pictograms alongside text instructions
to accommodate diverse linguistic backgrounds.
Correct answer: Visual aids help bridge language gaps in
medication counseling.
Rationale: Sociocultural inclusivity in communication